Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6505
    +0.0005 (+0.08%)
     

  • OIL

    82.70
    -0.11 (-0.13%)
     

  • GOLD

    2,330.70
    -7.70 (-0.33%)
     

  • Bitcoin AUD

    98,902.51
    -3,886.93 (-3.78%)
     

  • CMC Crypto 200

    1,394.47
    -29.63 (-2.08%)
     

  • AUD/EUR

    0.6072
    +0.0002 (+0.03%)
     

  • AUD/NZD

    1.0947
    +0.0005 (+0.04%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,144.12
    -57.15 (-0.33%)
     

  • NIKKEI 225

    37,919.50
    -540.58 (-1.41%)
     

Company News for May 26, 2020

Zacks Equity Research
·1-min read

  • Shares of Navidea Biopharmaceuticals, Inc. NAVB surged 91.3% after the biopharmaceutical company announced positive preliminary results from the second interim analysis of its ongoing NAV3-31 Phase 2B study.

  • Shares of Xeris Pharmaceuticals, Inc. XERS soared 28% after the specialty pharmaceutical company reported findings from outpatient portion of Phase 2 proof-of-concept study of its developmental ready-to-use glucagon in patients at risk of postprandial hypoglycemia following bariatric surgery.

  • Shares of T2 Biosystems, Inc. TTOO rose 12.8% after the in vitro diagnostics companysaid it expects to ship first SARS-CoV-2 tests to American customers as early as June-end.

  • Shares of Splunk Inc. SPLK gained 12.7% after the company reported first-quarter fiscal 2021 non-GAAP loss of 56 cents per share, which was lesser than the Zacks Consensus Estimate of a loss of 57 cents.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Splunk Inc. (SPLK) : Free Stock Analysis Report
 
Navidea Biopharmaceuticals, Inc. (NAVB) : Free Stock Analysis Report
 
T2 Biosystems, Inc. (TTOO) : Free Stock Analysis Report
 
Xeris Pharmaceuticals, Inc. (XERS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research